Fertility of Women Treated during Childhood with Triptorelin (Depot Formulation) for Central Precocious Puberty: The PREFER Study
Authors:
- Jean-Claude CarelJCJean-Claude Carel
- on behalf of the PREFER study groupOGon behalf of the PREFER study group
Open Access
- 26 March 2021
- journal article
- research article
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 93 (9-10) , 529-538
Abstract
Background: Gonadotropin-releasing hormone analogues (GnRHa) administered as depot formulations are the standard of care for children with central precocious puberty (CPP). Puberty resumes after treatment discontinuation, but little is known concerning fertility in women who have been treated with GnRHa for CPP during childhood. Methods: The PREFER (PREcocious puberty, FERtility) study prospectively analysed fertility, via a series of questionnaires, in women treated during childhood with triptorelin (depot formulation) for CPP. Co-primary endpoints were the proportion of women wanting a pregnancy any time before study inclusion and during the follow-up period but not pregnant 6 and 12 months after stopping contraception and the waiting time to pregnancy (WTP). Results: A total of 574 women were identified, and 194 women were included in the analysis. Although there were not enough data for primary endpoint assessment, few women (1.7%) reported issues with fertility or were unable to become pregnant despite trying to conceive. Most pregnancies (84.4%, 95% CI [67.2–94.7%]) occurred within 1 year of trying to conceive, in line with the WTP for women without previous CPP. Conclusion: The results, based on a limited sample of patients, suggest that CPP treated with triptorelin does not negatively impact women’s fertility in adulthood. These results need to be consolidated with a subsequent study performed when these women will have reached their mid-thirties.Keywords
This publication has 33 references indexed in Scilit:
- Central Precocious Puberty: Treatment with Triptorelin 11.25 mgThe Scientific World Journal, 2012
- Advanced Reproductive Age and FertilityInternational Journal of Gynecology & Obstetrics, 2011
- Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatmentGynecological Endocrinology, 2010
- Normal Adult Height Among Girls Treated for Central Precocious Puberty with Gonadotropin-Releasing Hormone Analog TherapyJournal of Pediatric Endocrinology and Metabolism, 2009
- Precocious PubertyNew England Journal of Medicine, 2008
- Detrimental psychological outcomes associated with early pubertal timing in adolescent girlsDevelopmental Review, 2007
- Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive functionMolecular and Cellular Endocrinology, 2006
- Comparison of Complete and Incomplete Suppression of Pituitary-Gonadal Activity in Girls with Central Precocious Puberty: Influence on Growth and Predicted Final HeightHormone Research, 1993
- Pubertal Development, Growth and Final Height in Girls with Sexual Precocity after Therapy with the GnRH Analogue D-TRP-6-LHRHHormone Research, 1990
- A Prospective Study of the Relation Between Smoking and FertilityInternational Journal of Epidemiology, 1988